BIL-010t

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameBIL-010t
Drug Alias NameAnti-nf-P2X7 antibodyBSCT 10% ointmentBIL-010t
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionP2X purinoceptor 7 antagonists
TargetsP2X purinoceptor 7
Therapy Area/IndicationsCarcinoma, Basal Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPeptech UkBiosceptre
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiosceptre
Active IndicationsN/A
Inactive IndicationsCarcinoma, Basal Cell

Other Information

ATC CodeN/A
Related LinksN/A